){kind=logo}
)
)
)
)
AgNavigator News
-
Spain-based Rovensa Next has secured R$45 million in Brazilian government-backed financing from FINEP to accelerate research and development of agricultural biosolutions, reinforcing Brazil’s growing role as a global center for biological crop inputs. The funding supports new biocontrol, bionutrition, and adjuvant products, with Brazil serving both as a major market and a hub for technology development and scaling. The country’s bioinputs sector has expanded rapidly, with significant increases in treated acreage and market value, underscoring the shift of biologicals from niche to mainstream in large-scale agriculture. Rovensa Next’s investments, including a new pilot fermentation plant, aim to connect market opportunities with innovative products that address both local and global agricultural challenges.
-
French cooperative bank Crédit Mutuel leverages its mutual ownership structure to invest patient capital in agriculture’s environmental transition, allocating 15% of annual net profits to sustainability initiatives through grants, low-interest loans, and impact investing. Notable programs include subsidised loans for new farmers tied to environmental requirements and investments in biosolutions like biocontrol and biostimulant technologies, with a focus on long-term impact over immediate returns. The bank’s strategy emphasizes flexible, mission-driven financing to address structural challenges and support generational renewal in farming. Crédit Mutuel’s approach reflects its 150-year legacy of supporting rural communities, now focused on sustainable agriculture and innovation.
-
Can AI predict the next big food crisis?
-
Biotechnology start-up Robigo has secured Series A funding led by Leaps by Bayer to commercialize its ARGO platform, which uses engineered microbes, RNAi, and CRISPR to develop scalable biopesticides targeting multiple crop diseases. Bayer’s investment is driven by the platform’s potential to rapidly generate diverse crop protection solutions, addressing challenges of efficacy, consistency, and cost that have hindered traditional biologicals. Robigo’s initial focus is on fungal diseases in soybeans and specialty crops, with ambitions to expand to additional pathogens and crops through both product sales and strategic partnerships. The company’s approach integrates synthetic biology with biological crop protection, aiming for sustainability and high performance without requiring changes to farm practices.
)
)
)
)
)
)
)
)
){kind=logo}
)
)